Results 111 to 120 of about 193,385 (155)
[Effect of body mass index on residual dizziness after repositioning in benign paroxysmal positional vertigo]. [PDF]
Yun Y +6 more
europepmc +1 more source
[[abstract]]Background: Human Uncoupling Protein 3 (UCP3) is a new candidate gene for human obesity. UCPJ has been shown to be regulated by thyroid hormone, 3-adrenergic agonists, leptin, and fat feeding in rodents. Mutations in exon 3 (V1O2I) and exon 4
Chen, Chih-Mei; Liu, Chiu-Shong; Wang, Nancy M. ; Lin, Cheng-Chieh
core
五味子乙素调节ROS/TXNIP/NLRP3信号通路对肥胖大鼠肝脏氧化应激及炎症反应的影响
目的探究五味子乙素(SchB)调节活性氧(ROS)/硫氧还蛋白结合蛋白(TXNIP)/NOD样受体相关蛋白3(NLRP3)信号通路对肥胖大鼠肝脏氧化应激及炎症反应的影响。方法通过喂养高脂饲料建立肥胖大鼠模型,将建模成功的SD大鼠随机分为模型组、SchB低、中、高剂量组(L-SchB组、M-SchB组、H-SchB组)、SchB高剂量+NLRP3信号通路激活剂Nigericin组(Nigericin组),另外随机选取等量健康SD大鼠标准饲料喂养为对照组 ...
于春林, 张孝堂, 蔡建军
doaj
[Association of metabolic syndrome and its components with gout: an analysis based on a large-scale health survey database]. [PDF]
Li J, Liu W.
europepmc +1 more source
非酒精性脂肪性肝病(Non-Alcoholic Fatty Liver Disease, NAFLD)是以肝脏脂质沉积过多为主要特征并伴有不同程度的炎症和损伤的一种临床病理综合征。NAFLD与酒精摄入无关,通常与肥胖、糖尿病、高血压和高血脂等代谢综合征相关。目前为止,我国大陆地区患病率约为29.81%高于全球的平均水平(25%),NAFLD已经超越乙型病毒性肝炎和酒精性肝病,成为中国最常见的慢性肝病。NAFLD在早期通常没有明显的症状,
张玉秀 +4 more
doaj
[Oral Health Status of Obese Children andIntervention Strategies]. [PDF]
Cheng R, Lei L, Zhang R, Cai H, Hu T.
europepmc +1 more source
[Natural history and risk factors of metabolic associated fatty liver disease in Chinese cohorts]. [PDF]
Zhang J, Zhan RX, Wang Y, Nan YM.
europepmc +1 more source
针对阿片类药物和胆石病因果关系的新见解:一项两样本孟德尔随机化研究
胆石症困扰着全球约10%~20%的成年人,影响了患者的生活质量,加重了经济负担[1]。胆石症的危险因素包括肥胖、糖尿病,胆囊动力障碍等[2]。阿片类药物是临床实践中常用的一组镇痛药,广泛应用于全身麻醉的诱导、维持及围术期镇痛治疗[3-5]。然而,滥用阿片类药物可能导致成瘾和其他严重的健康风险,如呼吸抑制[6-7]。新近有研究报道:阿片类药物可能是胆石症发生的一项影响因素[8]。与随机对照实验(RCT)方法对比,孟德尔随机化(MR ...
于馨洁, 潘振祥
doaj
[Acupuncture alleviates chronic airway inflammation in obese asthmatic mice by downregulating Vnn1 and FAM126B]. [PDF]
Li X, Ye T, Xi L, Li C, Liu H.
europepmc +1 more source
[Research progress in mechanisms of dietary resistant starch for regulating glucose and lipid metabolism]. [PDF]
Liu K, Li X, Zhang Y, Sun J, Liao W.
europepmc +1 more source

